PRPONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Precipio, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$21.89+0.52 (+2.41%)
Close on Oct 19, 2026
- Market cap
- $39.12M
- P/E (TTM)
- –
- Dividend yield
- –
Precipio, Inc. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2014 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Single reportable segment | $24.05M | $18.53M | $15.20M | – | – | – | – | – | – | – | 100.0% | +29.8% |
| Laboratory Services | – | – | – | – | – | – | – | – | – | $16.52M | – | – |
| Genetic Assays and Platforms | – | – | – | – | – | – | – | – | – | $10.56M | – | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2014 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Service revenue, net | $21.31M | $15.92M | $12.18M | $8.01M | $7.94M | $5.87M | $3.08M | $2.75M | $1.39M | – | 88.6% | +33.8% |
| Product revenue | $2.74M | $2.61M | $3.02M | – | – | – | – | – | – | – | 11.4% | +4.9% |
| Biomarker Testing and Clinical Project Services [Member] | – | – | – | – | – | – | $595.00K | $1.19M | $491.00K | – | – | – |
| Diagnostic Testing [Member] | – | – | – | – | – | – | $3.46M | $2.15M | $1.21M | – | – | – |
| Clinical research grants [Member] | – | – | – | – | – | – | – | $100.00K | $278.00K | – | – | – |
| Other revenue | – | – | $3.02M | $1.40M | $914.00K | $220.00K | $44.00K | $13.00K | $53.00K | – | – | – |
| Clinical Research Grants and Other [Member] | – | – | – | – | – | – | $44.00K | $113.00K | $336.00K | – | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2014 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Italy | – | – | – | – | – | – | – | – | – | $1.26M | – | – |
| United Kingdom | – | – | – | – | – | – | – | – | – | $881.00K | – | – |
| United States | – | – | – | – | – | – | – | – | – | $21.05M | – | – |
| All Other Countries | – | – | – | – | – | – | – | – | – | $3.89M | – | – |
From the segment and revenue-disaggregation notes of Precipio's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.